Understanding oropharyngeal carcinoma and its connection to HPV

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to enhance the understanding of the natural history of oropharyngeal carcinoma (OPC), particularly in relation to human papilloma virus (HPV). Researchers will collect blood samples from patients diagnosed with OPC before treatment and at six follow-up time points to analyze changes over time. The study focuses on both HPV-associated and non-associated cases to provide a comprehensive profile of the disease. By gathering this data, the study seeks to uncover insights that could inform future treatment strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients diagnosed with oropharyngeal carcinoma or patients with cancer of the unknown primary that is HPV associated, or possibly deemed to be originating from the oropharynx.

Exclusion Criteria:

* Not willing to sign consent

Where it's running

• Stanford University
  Palo Alto, California, United States Recruiting

Study contacts

• Principal investigator: Chris Holsinger, MD — Stanford University
• Study coordinator: Nikita Bedi
• Email: nbedi@stanford.edu
• Phone: (650) 723-5957

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Lower radiation therapy combined with standard chemotherapy for HPV-positive throat cancer

  This study is testing whether using less radiation therapy along with standard chemotherapy can help people with HPV-positive throat cancer feel better while causing fewer side effects.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT05491512

• Intraoperative Methadone for Postoperative Pain in Head and Neck Cancer Patients

  This trial tests whether giving methadone during surgery, in addition to standard fentanyl, helps control pain after head and neck cancer surgery more effectively than fentanyl alone.

  Recruiting Phase 4 OHSU Knight Cancer Institute · Portland, Oregon · NCT07857655

• Mild heat therapy added to standard treatment for locally advanced head and neck cancer

  This early-stage trial tests whether mild hyperthermia can be safely added to standard radiotherapy with or without chemotherapy for locally advanced head and neck cancer.

  Recruiting Phase 1 Erasmus Medical Center · Rotterdam, South Holland · NCT07690618

• HPV self-sampling in the ED to screen under-screened women

  This study tests whether giving an HPV self-sampling kit in the emergency department can help under-screened women get screened for cervical cancer and find those with HPV to guide follow-up care.

  Recruiting Rutgers, The State University of New Jersey · New Brunswick, New Jersey and 1 other locations · NCT07657104

• Transoral and neck ultrasound to find suspected oropharyngeal (throat) cancers

  This study will test whether adding transoral and neck ultrasound to the usual diagnostic tests helps doctors find oropharyngeal (throat) cancers more accurately in adults referred for suspicion of oropharyngeal cancer.

  Recruiting Copenhagen University Hospital, Rigshospitalet · Aarhus and 3 other locations · NCT07548268

• Selective dose reduction of neck radiation in HPV-associated oropharyngeal cancer

  This trial tests whether lowering radiation doses to certain neck lymph nodes or gross disease areas is safe and can reduce side effects for adults with HPV-related oropharyngeal cancer.

  Recruiting at 4 sites Phase 2 University of Maryland, Baltimore · Baltimore, Maryland and 3 other locations · NCT07418034

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.